Literature DB >> 14992899

Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot.

Bo Wei1, Yinglong Liu, Qiang Wang, Cuntao Yu, Cun Long, Yongnan Chang, Yingmao Ruan.   

Abstract

BACKGROUND: The aim of this study was to evaluate the protective effect of pulmonary perfusion with hypothermic protective solution on lung function after cardiopulmonary bypass in corrections of Tetralogy of Fallot.
METHODS: Sixty-four consecutive children with Tetralogy of Fallot were randomly divided into a control group (n = 30) and a protective group (n = 34). Hypothermic protective solution was infused to the main pulmonary artery in the protective group. Hemodynamics and lung functions were monitored. Concentrations of malondialdehyde, tumor necrosis factor-alpha, von Willebrand factor, and endothelin in plasma were measured. The interleukin-6 and interleukin-8 levels in bronchoalveolar lavage fluid were also determined. Lung biopsy specimens were obtained after weaning from cardiopulmonary bypass.
RESULTS: Oxygenation values (oxygen index and alveolar-arterial O(2) gradient) were better preserved in the protective group than in the control group. The time of mechanical ventilation and length of intensive care unit stay were shorter in the protective group compared with the control group. The tumor necrosis factor-alpha and malondialdehyde levels in plasma increased in both groups after operations, and the rising extents were lower in the protective group than in the control group. The von Willebrand factor and endothelin levels in plasma increased more significantly in the control group than in the protective group. The concentrations of interleukin-6 and interleukin-8 in bronchoalveolar lavage fluid were lower in the protective group than in the control group. The examination of histopathology demonstrated capillary hyperemia and hemorrhage, intra-alveolar edema, leukocytes accumulation, mitochondria swelling and vacuolation, and gas-blood barrier broadening in the control group, whereas there were no significant changes in the protective group. The intercellular adhesion molecule-1 expression on lung vascular endothelial cells was stronger in the control group.
CONCLUSIONS: Lung perfusion with hypothermic protective solution during cardiopulmonary bypass relieved lung injury in corrections of Tetralogy of Fallot. The inhibition of lung vascular endothelial cell injury may be the major mechanism of relieving cardiopulmonary bypass-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992899     DOI: 10.1016/j.athoracsur.2003.09.072

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Lung Protection Strategies during Cardiopulmonary Bypass Affect the Composition of Blood Electrolytes and Metabolites-A Randomized Controlled Trial.

Authors:  Katrine B Buggeskov; Raluca G Maltesen; Bodil S Rasmussen; Munsoor A Hanifa; Morten A V Lund; Reinhard Wimmer; Hanne B Ravn
Journal:  J Clin Med       Date:  2018-11-21       Impact factor: 4.241

2.  A novel and stable "two-hit" acute lung injury model induced by oleic acid in piglets.

Authors:  Xiaofeng Li; Yinglong Liu; Qiang Wang; Yaobin Zhu; Xiaodong Lv; Jinping Liu
Journal:  Acta Vet Scand       Date:  2009-03-30       Impact factor: 1.695

Review 3.  Pulmonary artery perfusion versus no perfusion during cardiopulmonary bypass for open heart surgery in adults.

Authors:  Katrine B Buggeskov; Lars Grønlykke; Emilie C Risom; Mao Ling Wei; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2018-02-08

4.  Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial.

Authors:  Katrine B Buggeskov; Martin M Sundskard; Thomas Jonassen; Lars W Andersen; Niels H Secher; Hanne B Ravn; Daniel A Steinbrüchel; Janus C Jakobsen; Jørn Wetterslev
Journal:  BMJ Open Respir Res       Date:  2016-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.